Department of Biochemistry and Molecular Biophysics

Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy

(Jun 13th, 2020)

Shuang Li, Shixuan Liu, Xiaoran Roger Liu, Mengru Mira Zhang, and Weikai Li. (2020). “Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy” Blood Adv. 2020 May 26; 4(10): 2202–2212. Published online 2020 May 20. doi: 10.1182/bloodadvances.2020001750 (Abstract)